Nathan D Goldman sold $4.2M of CSX
EVP & CLO at CSX CORP. 118,588 shares at an average of $35.39, traded Nov 18, 2024, filed Nov 20, 2024.
Score components
- +15RoleOfficer
- +25Trade size$4.2M at market
- +10Share of holdings soldSold 47% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -7.6%, 3m -5.9%, 6m -11.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-129363, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 18, 2024 | SOpen-market sale Common Stock | -48,588 | $35.40 | $1.7M | 202,991 | Nov 20, 2024 |
| Nov 18, 2024 | MOption exercise Common Stock | +70,000 | $22.69 | $1.6M | 272,991 | Nov 20, 2024 |
| Nov 18, 2024 | SOpen-market sale Common Stock | -70,000 | $35.39 | $2.5M | 202,991 | Nov 20, 2024 |
| Nov 18, 2024 | MOption exercise Optionderivative | -70,000 | $0.00 | $0 | 67,301 | Nov 20, 2024 |
Related signals
Other insiders at CSX CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 21Weak | CSXsell CSX CORP | Stephen Fortune EVP - CD&TO | $47k 1,500 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.